Assessment of efficacy and immunomodulatory effects of metronomic therapy in dogs with non resectable primary or metastatic carcinomas
People: Ana Lara
The oncology service at the Royal Veterinary College is currently investigating the use of Metronomic therapy (MT) which is an oral treatment combined with an anti-inflammatory and an anticancer drug as a treatment for dogs with cancer.
People: Brian Catchpole
At The Royal Veterinary College we have established a national canine diabetes register. This includes a database of clinical information and an archive of residual samples. This diabetic register should allow us to progress our understanding of the causes of this disease.
Comparison of prolene suture material versus cellophane band for partial attenuation of congenital portosystemic shunts in dogs
People: Vicky Lipscomb
As part of our continued effort to improve treatment options available to pets, we are currently conducting a study investigating the use of prolene suture material versus cellophane band for partial attenuation of congenital portosystemic shunts in dogs.
Correlation of genotype with phenotype: Moving towards individual pharmacogenomic treatment for canine inflammatory bowel disease
At the Royal Veterinary College, We are investigating the genetic cause of Inflammatory Bowel Disease (IBD) in German shepherd dogs (GSDs), part of which we will be setting up a new DNA archive of GSD samples. We are looking for blood or saliva samples from GSDs that have been diagnosed with IBD as ‘cases’, and from GSDs without IBD that are over 8 years old as ‘controls’.
The Diabetic Remission Clinic investigates the optimum management for diabetic cats, and cats in diabetic remission. This includes investigating factors that increase the chance of diabetic remission and prevent cats in remission from relapsing. The clinic is opening a new clinical trial to investigate the benefit of a drug promoting insulin secretion in preventing relapse of diabetes mellitus.
Exploring the types of treatment currently in use for management of immune-mediated haemolytic anaemia in the dog
We are conducting an online survey to explore the different types of treatment currently in use for management of canine immune-mediated haemolytic anaemia (IMHA) in the UK
At the Queen Mother Hospital for Animals we are conducting a study using sensory testing to establish if it could be a useful tool in the diagnosis and treatment of Nep in animals. This is a non-invasive and interactive study for both pets and their owners.
We are carrying out a study focussing on the impact of Imepitoin on the behaviour of dogs diagnosed with idiopathic epilepsy. As we hope to look at the potential behavioural effects of this drug in isolation, we wish to recruit drug-naive dogs diagnosed with idiopathic epilepsy.
Investigating the Effects of Ketogenic Medium-Chain Triglyceride (MCT) Supplement on Canine Epilepsy
At the Queen Mother Hospital for Animals we are carrying out a study focusing on the dietary effects of Medium-Chain Triglyceride (MCT) oil given as a daily supplement on seizure frequency, severity, and behavioural co-morbidities of dogs diagnosed with idiopathic epilepsy. This study includes, besides complete blood check-up, non-invasive and interactive behavioural tests on cognition, anxiety, and gait.
The long-term influence of a medium chain fatty acid diet on canine idiopathic epilepsy - LifeTIME (Long Term remission Mct Epilepsy) study
Dietary management for epilepsy is commonly used in humans, and recent studies at RVC have demonstrated that a diet containing medium-chain-triglycerides (MCTs) can reduce seizure frequency, and improve behaviour in some dogs with epilepsy. The purpose of the present trial is to confirm the efficacy of an MCT enriched diet in the management of dogs with idiopathic epilepsy. We will use a parallel design, which means that your dog will either receive a standard high-quality diet or the same diet enriched with MCT.